ChromaDex’s Pterostilbene Gets GRAS

June 20, 2011

The company adds that the first human clinical trial to evaluate pTeroPure’s effects in patients with lipid, or cholesterol, disorders is underway at the University of Mississippi.

ChromaDex Corp.’s (Irvine, CA) pTeroPure pterostilbene ingredient has received generally recognized as safe (GRAS) status for potential use in food and beverages.

The ingredient is said to be an ultrapure form of the naturally occurring compound pterostilbene, which is found in blueberries. It has potential for supporting heart health through maintaining healthy cholesterol and blood pressure levels, while also providing additional benefits for cognitive function and healthy aging.

“The industry experts from the American Institute for Biosocial and Medical Research, including former U.S. Department of Agriculture and FDA staffers, all agreed that pTeroPure merits this designation,” stated Frank Jaksch, ChromaDex’s CEO.

The company adds that the first human clinical trial to evaluate pTeroPure’s effects in patients with lipid, or cholesterol, disorders is underway at the University of Mississippi. Primary markers being studied are high- and low-density lipoprotein cholesterol. Secondary endpoints include blood pressure, markers of oxidative stress, and safety.

The ingredient was also named the 2010 North American Most Promising Ingredient of the Year by Frost & Sullivan.